Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2024 08:00 ET | Source: Third Pole Therapeutics

Third Pole Therapeutics Announces Successful Completion of Feasibility Study with eNOfit™ Portable Inhaled Nitric Oxide Delivery System

WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Third Pole Therapeutics, a privately held company developing critical life-sustaining therapies for people living with cardiopulmonary and...
December 11, 2023 16:05 ET | Source: Third Pole Therapeutics

Third Pole Therapeutics Announces First Patient Dosed in Feasibility Study with eNOfit™ Portable Inhaled Nitric Oxide Delivery System

WALTHAM, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Third Pole Therapeutics, Inc., a privately held company developing critical life-sustaining therapies for people living with cardiopulmonary and...
December 14, 2022 08:00 ET | Source: Third Pole Therapeutics

Third Pole Therapeutics Receives $32M Strategic Equity Investment to Accelerate its Tankless Inhaled Nitric Oxide (iNO) Platform

Funding will support the final development phase prior to planned 2023 FDA submission of the company’s “breakthrough” designated eNOcare™ hospital device WALTHAM, Mass., Dec. 14, 2022 (GLOBE...